ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04621	NOD-like receptor signaling pathway	12/75	157/7206	6.00190462886e-08
ko05164	Influenza A	12/75	167/7206	1.191015451e-07
ko04668	TNF signaling pathway	10/75	120/7206	3.74695720709e-07
ko04060	Cytokine-cytokine receptor interaction	12/75	191/7206	5.15933133272e-07
ko05167	Kaposi's sarcoma-associated herpesvirus infection	12/75	191/7206	5.15933133272e-07
ko04064	NF-kappa B signaling pathway	9/75	96/7206	5.50541923277e-07
ko04380	Osteoclast differentiation	10/75	134/7206	1.04807240429e-06
ko05152	Tuberculosis	11/75	187/7206	3.08563240788e-06
ko04623	Cytosolic DNA-sensing pathway	6/75	41/7206	3.49663044759e-06
ko05161	Hepatitis B	10/75	173/7206	1.05549526919e-05
ko05168	Herpes simplex infection	10/75	182/7206	1.64819389478e-05
ko04662	B cell receptor signaling pathway	7/75	88/7206	3.22440852809e-05
ko04622	RIG-I-like receptor signaling pathway	6/75	62/7206	4.02213947943e-05
ko05145	Toxoplasmosis	8/75	126/7206	4.42232699214e-05
ko04658	Th1 and Th2 cell differentiation	7/75	96/7206	5.665661344e-05
ko04630	Jak-STAT signaling pathway	8/75	132/7206	6.16835902955e-05
ko04217	Necroptosis	9/75	178/7206	8.63727082477e-05
ko04210	Apoptosis	9/75	180/7206	9.41504023888e-05
ko05160	Hepatitis C	8/75	153/7206	0.000173927827971
ko05162	Measles	7/75	120/7206	0.000231803033736
ko04660	T cell receptor signaling pathway	7/75	124/7206	0.000283770447722
ko05140	Leishmaniasis	5/75	75/7206	0.00104513967767
ko04612	Antigen processing and presentation	5/75	77/7206	0.00117730575558
ko04657	IL-17 signaling pathway	5/75	87/7206	0.00203143610551
ko05142	Chagas disease (American trypanosomiasis)	6/75	130/7206	0.00223443804478
ko05321	Inflammatory bowel disease (IBD)	4/75	56/7206	0.00264102731673
ko04620	Toll-like receptor signaling pathway	5/75	100/7206	0.00372863300653
ko04062	Chemokine signaling pathway	7/75	201/7206	0.0047225977272
ko04659	Th17 cell differentiation	5/75	106/7206	0.00478307756514
ko05169	Epstein-Barr virus infection	7/75	206/7206	0.00539651222052
ko05215	Prostate cancer	5/75	111/7206	0.00581149437066
ko04672	Intestinal immune network for IgA production	3/75	37/7206	0.00652774799959
ko05203	Viral carcinogenesis	8/75	277/7206	0.00779693144543
ko05166	HTLV-I infection	8/75	292/7206	0.0105552236136
ko04917	Prolactin signaling pathway	4/75	87/7206	0.0125718142494
ko05133	Pertussis	4/75	87/7206	0.0125718142494
ko05222	Small cell lung cancer	4/75	89/7206	0.0135780548257
ko04931	Insulin resistance	5/75	137/7206	0.0137607685681
ko05120	Epithelial cell signaling in Helicobacter pylori infection	4/75	92/7206	0.0151814729036
ko04650	Natural killer cell mediated cytotoxicity	4/75	97/7206	0.0181109503321
ko05146	Amoebiasis	4/75	99/7206	0.0193747385092
ko00512	Mucin type O-glycan biosynthesis	2/75	29/7206	0.0362071527044
ko05340	Primary immunodeficiency	2/75	30/7206	0.0385367312905
ko05134	Legionellosis	3/75	74/7206	0.0414785278233
ko05014	Amyotrophic lateral sclerosis (ALS)	3/75	74/7206	0.0414785278233
ko04115	p53 signaling pathway	3/75	74/7206	0.0414785278233
ko01524	Platinum drug resistance	3/75	76/7206	0.044331178792
ko04664	Fc epsilon RI signaling pathway	3/75	77/7206	0.0457934998833
ko04010	MAPK signaling pathway	7/75	321/7206	0.0486776764825